Fintel reports that on April 21, 2025, B of A Securities upgraded their outlook for United Therapeutics (NasdaqGS:UTHR) from ...

BofA upgraded United Therapeutics (UTHR) to Neutral from Underperform with a $314 price target Stay Ahead of the Market: Discover ...

As previously reported, BofA analyst Jason Gerberry upgraded United Therapeutics (UTHR) to Neutral from Underperform with an unchanged price ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (UTHR) announced today that it will report its first quarter 2025 financial results before the ...

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., April 16, 2025--United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its first quarter 2025 financial results ...

In experiments with four deceased bodies, that “bridge” attempt showed the pig liver could support some functions of a human liver for two or three days, said Mike Curtis, CEO of Massachusetts-based ...

Other trials are testing pig kidneys from both eGenesis and United Therapeutics in experimental transplants, the Associated Press reported.

About Unither Bioélectronique Unither Bioélectronique, Inc. (UB), a wholly owned subsidiary of United Therapeutics Corporation, is driving the innovation and development of autonomous, environmentally ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The kidney was removed Friday, The Times said. United Therapeutics Corporation, the biotech company that created the pig used in the transplant, said the organ had functioned well until the ...